These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25407099)

  • 21. A milestone in house dust-mite-allergen immunotherapy: the new sublingual tablet S-524101 (actair).
    Bahceciler NN; Babayigit Hocaoglu A; Galip N
    Expert Rev Vaccines; 2014 Dec; 13(12):1427-38. PubMed ID: 25345538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of new respiratory allergies in patients monosensitized to airborne allergens in the area north of Milan.
    Asero R
    J Investig Allergol Clin Immunol; 2004; 14(3):208-13. PubMed ID: 15552714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
    J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences and similarities between sublingual immunotherapy of allergy and oral tolerance.
    Moingeon P; Mascarell L
    Semin Immunol; 2017 Apr; 30():52-60. PubMed ID: 28760498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of respiratory allergy with allergy immunotherapy tablets.
    Bachert C
    Allergy; 2011 Jul; 66 Suppl 95():57-9. PubMed ID: 21668858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allergy immunotherapy: what is the evidence for cost saving?
    Hankin CS; Cox L
    Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):363-70. PubMed ID: 24936851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral/sublingual Phleum pretense grass tablet (Grazax/Grastek) to treat allergic rhinitis in the USA.
    Nelson HS
    Expert Rev Clin Immunol; 2014 Nov; 10(11):1437-51. PubMed ID: 25340426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis".
    Demoly P; Calderon MA; Casale TB; Malling HJ; Wahn U
    Clin Transl Allergy; 2015; 5():18. PubMed ID: 25941566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sublingual immunotherapy for pediatric allergic rhinitis: The clinical evidence.
    Poddighe D; Licari A; Caimmi S; Marseglia GL
    World J Clin Pediatr; 2016 Feb; 5(1):47-56. PubMed ID: 26862501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sublingual immunotherapy: recent advances.
    Compalati E; Braido F; Walter Canonica G
    Allergol Int; 2013 Dec; 62(4):415-23. PubMed ID: 24280671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pediatric sublingual immunotherapy efficacy: evidence analysis, 2009-2012.
    Larenas-Linnemann D; Blaiss M; Van Bever HP; Compalati E; Baena-Cagnani CE
    Ann Allergy Asthma Immunol; 2013 Jun; 110(6):402-415.e9. PubMed ID: 23706708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber.
    Horak F; Zieglmayer P; Zieglmayer R; Lemell P; Devillier P; Montagut A; Mélac M; Galvain S; Jean-Alphonse S; Van Overtvelt L; Moingeon P; Le Gall M
    J Allergy Clin Immunol; 2009 Sep; 124(3):471-7, 477.e1. PubMed ID: 19647862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
    Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
    Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in upper airway diseases and allergen immunotherapy.
    Nelson HS
    J Allergy Clin Immunol; 2007 Apr; 119(4):872-80. PubMed ID: 17292953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: a double-blind, placebo-controlled study.
    Wahn U; Klimek L; Ploszczuk A; Adelt T; Sandner B; Trebas-Pietras E; Eberle P; Bufe A;
    J Allergy Clin Immunol; 2012 Oct; 130(4):886-93.e5. PubMed ID: 22939758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sublingual-oral administration of standardized allergenic extracts: phase 1 safety and dosing results.
    Esch RE; Bush RK; Peden D; Lockey RF
    Ann Allergy Asthma Immunol; 2008 May; 100(5):475-81. PubMed ID: 18517081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sublingual immunotherapy for allergic rhinoconjunctivitis--the seeming and the real.
    Reider N
    Int Arch Allergy Immunol; 2005 Jul; 137(3):181-6. PubMed ID: 15947473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in basophil activation during grass-pollen sublingual immunotherapy do not correlate with clinical efficacy.
    Van Overtvelt L; Baron-Bodo V; Horiot S; Moussu H; Ricarte C; Horak F; Zieglmayer P; Zieglmayer R; Montagut A; Galvain S; de Beaumont O; Le Gall M; Moingeon P
    Allergy; 2011 Dec; 66(12):1530-7. PubMed ID: 21883279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen.
    Rolinck-Werninghaus C; Kopp M; Liebke C; Lange J; Wahn U; Niggemann B
    Int Arch Allergy Immunol; 2005 Feb; 136(2):134-41. PubMed ID: 15650310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
    Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
    Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.